30 Aug 2023 IGG announced 1H23 results w
CROSBY Research – IGG (799 HK/BUY): Multiple growth drivers from Doomsday, Viking Rise, and App business
CROSBY Research – China Lesso (2128 HK/BUY): A resilient set of 1H23 results
29 Aug 2023 Despite the market uncertain
CROSBY Research – Wasion Holdings (3393 HK/BUY): A solid set of 1H23 results, indicating a good FY23
28 Aug 2023 Wasion’s 1H23 turnover incre
CROSBY Research – Sunny Optical (2382 HK/BUY): HLS/HCM shipment bottom out and sequential GPM improvement in 2H23
28 Aug 2023 Sunny reported 1H23 revenue
CROSBY Research – Anta (2020 HK/BUY): Solid 1H23 results with expanding OPM
25 Aug 2023 Anta’s 1H23 revenue was up b
CROSBY Research – Canvest (1381 HK/BUY): Higher revenue contribution from operation segment
25 Aug 2023 1H23 revenue down by 28% YoY
CROSBY Research – Xtep (1368 HK/BUY): Solid 1H23 revenue growth, full year sales growth target 15-20% YoY
24 Aug 2023 Xtep’s 1H23 revenue was up b
CROSBY Research – Vincent Medical (1612 HK/BUY): Staging a turnaround in 1H23
24 Aug 2023 In 1H23, Vincent Medical’s (
CROSBY Research – Pagoda (2411 HK): Widening NPM on operational efficiency and cost savings
22 Aug 2023 The company reported a 6.4%
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 41)
21 Aug 2023 Hong Kong’s population